4D Molecular Therapeutics

📍 Emeryville, United States🗓 Founded 2013👥 234 employees💰 Last funded Nov 2020
Biotechnology Research🌐 4dmoleculartherapeutics.com
Website LinkedIn
4DMT is a clinical stage biopharma company inventing and developing innovative products to unlock the full potential of genetic medicine to treat large market and rare diseases. Our vector discovery platform Therapeutic Vector Evolution harnesses the power of directed evolution, a Nobel Prize-winning technology, with approximately one billion synthetic AAV capsid-derived sequences to invent customized and evolved vectors with improved therapeutic profiles compared to wild-type vectors. Our product design, development and manufacturing engine empowers us to efficiently create our valuable and diverse product pipeline. This combination of bold innovation and relentless execution gives 4DMT the capability to revolutionize genetic medicines and to strive for potential curative therapies. We have built a deep portfolio of genetic medicine product candidates, with five product candidates in clinical trials for seven patient populations. We are taking genetic medicine to new heights and into new disease areas to overcome challenges not addressed by existing medicines. This incredible challenge drives our relentless and talented team. Our people are the essence of our inspiring, innovative and collaborative environment that encourages individual contributions and provides opportunities for career development. We seek the best in the industry who identify with our mission and our bold and innovative results-driven approach. Our 4 Guiding Principles drive the way we work together: - Dare to Cure - Break Boundaries - Beyond Yourself - Prepare & Execute Relentlessly Join us in creating the future of genetic medicine.
5
Total investors
0
Early stage
2
Mid stage
3
Late stage
2013
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Investor activity2018–2020 · investors recorded per year
201822019120202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in 4D Molecular Therapeutics?
4D Molecular Therapeutics has 5 investors on record on gritt.io, 2 mid-stage and 3 late-stage investors.
When did 4D Molecular Therapeutics last raise funding?
The most recent investment in 4D Molecular Therapeutics recorded on gritt.io was in November 2020.
When was 4D Molecular Therapeutics founded?
4D Molecular Therapeutics was founded in 2013.
What industry is 4D Molecular Therapeutics in?
4D Molecular Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is 4D Molecular Therapeutics based?
4D Molecular Therapeutics is headquartered in Emeryville, United States.